This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, J. C. Articles by Davies, J. S. Search for Related Content PubMed PubMed Citation Articles by Smith, J. C. Articles by Davies, J. S.

Augmentation of Central Arterial Pressure in Mild Primary Hyperparathyroidism

Departments of Medicine (J.C.S., M.D.P., M.F.S., J.S.D.), Biochemistry (R.J.), Surgery (M.H.W.), and Cardiology (J.R.C.), University Hospital of Wales, Cardiff CF14 4XW, United Kingdom

Address all correspondence and requests for reprints to: Dr. J. C. Smith, Department of Medicine, University Hospital of Wales, Cardiff CF14 4XW, United Kingdom.

Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular risk, although the mechanisms involved remain unclear. Recent evidence has shown increased pulse pressure to be a powerful predictor of cardiovascular events. As increases in pulse pressure are due largely to arterial stiffening, we measured arterial stiffness in 21 subjects with PHPT (18 women and 3 men; 46–71 yr old) and 21 age- and sex-matched healthy controls using pulse wave analysis, a technique that measures peripheral arterial pressure waveforms and generates corresponding central aortic waveforms. This allows determination of the augmentation of central pressure resulting from wave reflection and augmentation index, a measure of vessel stiffness. Metabolic parameters were also measured.

The serum calcium level among PHPT subjects was (mean ± SD) 2.74 ± 0.14 mmol/L. pulse wave analysis showed that both augmentation and the augmentation index were significantly higher in the PHPT group vs. controls [16 ± 5 vs. 10 ± 4 mm Hg (P < 0.001) and 36 ± 9% vs. 25 ± 6% (P < 0.001)] despite comparable brachial systolic pressures between groups (136 ± 13 vs. 134 ± 18 mm Hg). Patients with PHPT had higher fasting serum insulin levels [median (range), 15.8 (7.4–39.4) vs. 11.6 (5.1–23) mU/L; P < 0.05] and triglyceride (1.6 ± 0.6 vs. 1.2 ± 0.4 mmol/L; P < 0.05), but lower high density lipoprotein cholesterol (1.4 ± 0.4 vs. 1.6 ± 0.3 mmol/L; P < 0.05).

These data indicate that subjects with mild PHPT (calcium, <3.0 mmol/L) have increased arterial stiffness, as evidenced by higher augmentation of central aortic pressures. Enhanced vessel stiffness may arise from a combination of structural and functional vascular changes due to hypercalcemia and/or metabolic abnormalities. Increased vascular stiffness in subjects with PHPT may account in part for the increased cardiovascular risk in this group.

This article has been cited by other articles:

				N L Mills, J J Miller, A Anand, S D Robinson, G A Frazer, D Anderson, L Breen, I B Wilkinson, C M McEniery, K Donaldson, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk Thorax, April 1, 2008; 63(4): 306 - 311. [Abstract] [Full Text] [PDF]

				L. Craver, M. P. Marco, I. Martinez, M. Rue, M. Borras, M. L. Martin, F. Sarro, J. M. Valdivielso, and E. Fernandez Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1171 - 1176. [Abstract] [Full Text] [PDF]

				E. Hagstrom, E. Lundgren, J. Rastad, and P. Hellman Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol., July 1, 2006; 155(1): 33 - 39. [Abstract] [Full Text] [PDF]

				M. R. Rubin, M. S. Maurer, D. J. McMahon, J. P. Bilezikian, and S. J. Silverberg Arterial Stiffness in Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3326 - 3330. [Abstract] [Full Text] [PDF]

				P. Andersson, E. Rydberg, and R. Willenheimer Primary hyperparathyroidism and heart disease -- a review Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787. [Abstract] [Full Text] [PDF]

				B. A. Mullan, C. N. Ennis, H. J. P. Fee, I. S. Young, and D. R. McCance Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1262 - H1268. [Abstract] [Full Text] [PDF]

				F. Fallo, G. Camporese, E. Capitelli, G. M. Andreozzi, F. Mantero, and F. Lumachi Ultrasound Evaluation of Carotid Artery in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2096 - 2099. [Abstract] [Full Text] [PDF]